Login to Your Account



Amyloid Out or Combo?

Tau Gains Popularity as Alzheimer's Drug Target

By Brian Orelli
BioWorld Insight Contributing Writer

Monday, July 2, 2012

Just as multiple drugs targeting amyloid-beta are set to read out Phase III results, a new Alzheimer's disease target, tau, is gaining popularity.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription